Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma
Mehdi Siddiqui,1,* Joshua Iltis,1,* Petar Yanev,1 John Sladic,1 Charles Huynh,1 Daniel Nolan,2 Michael Singer2 1Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA; 2Medical Center Ophthalmology Associates, San Antonio, TX, USA *These authors contributed equally t...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd1be763babf43ad9c80030ff97ac9a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fd1be763babf43ad9c80030ff97ac9a4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fd1be763babf43ad9c80030ff97ac9a42021-12-02T05:05:16ZEffect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma1177-5483https://doaj.org/article/fd1be763babf43ad9c80030ff97ac9a42019-01-01T00:00:00Zhttps://www.dovepress.com/effect-of-systemic-antihypertensives-on-change-in-intraocular-pressure-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Mehdi Siddiqui,1,* Joshua Iltis,1,* Petar Yanev,1 John Sladic,1 Charles Huynh,1 Daniel Nolan,2 Michael Singer2 1Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA; 2Medical Center Ophthalmology Associates, San Antonio, TX, USA *These authors contributed equally to this work Purpose: There is a limited understanding of factors that influence the efficacy of topical glaucoma medication. Our study is a long-term, case–control analysis of how systemic antihypertensive (anti-HTN) medications influence the change in IOP after initiating prostaglandin (PG) drop therapy.Materials and methods: A retrospective chart review of 3,781 patients was performed on patients with a diagnosis of glaucoma suspect that progressed to primary open-angle glaucoma (POAG) by ICD-9 codes over a 10-year period. Inclusion criteria consisted of the following: 1) progression from preglaucoma to glaucoma diagnosis in a time span of ≥6 months; 2) two visual fields recorded between these dates; 3) initial average IOP of both eyes of ≥21 mmHg; and 4) initiation of topical PG therapy alone. IOP (in mmHg) was measured at initiation of PG drops and at next visit.Results: One hundred eleven patients were qualified for analysis. Patients not on anti-HTN agents had an average IOP decrease of 6.38±0.56 mmHg. Comparatively, patients on anti-HTN agents had an average IOP decrease of 6.66±0.48 mmHg (P=0.61). In addition, there was no statistical difference between IOP decrease between patients on single vs multiple systemic anti-HTN agents (P=0.85). There were eight nonresponders to PGs on no anti-HTN medications and 12 nonresponders on anti-HTN medication (P=0.55).Conclusion: Systemic anti-HTN medication use did not significantly impact IOP reduction after topical PG initiation for POAG. Additionally, nonresponse to PG therapy was not correlated to systemic anti-HTN use. Keywords: glaucoma, topical prostaglandins, IOP, systemic antihypertensives, ocular hypertension, prostaglandin eye dropsSiddiqui MIltis JYanev PSladic JHuynh CNolan DSinger MDove Medical Pressarticleglaucomatopical prostaglandinsintraocular pressuresystemic anti-hypertensivesOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 13, Pp 207-213 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
glaucoma topical prostaglandins intraocular pressure systemic anti-hypertensives Ophthalmology RE1-994 |
spellingShingle |
glaucoma topical prostaglandins intraocular pressure systemic anti-hypertensives Ophthalmology RE1-994 Siddiqui M Iltis J Yanev P Sladic J Huynh C Nolan D Singer M Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma |
description |
Mehdi Siddiqui,1,* Joshua Iltis,1,* Petar Yanev,1 John Sladic,1 Charles Huynh,1 Daniel Nolan,2 Michael Singer2 1Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA; 2Medical Center Ophthalmology Associates, San Antonio, TX, USA *These authors contributed equally to this work Purpose: There is a limited understanding of factors that influence the efficacy of topical glaucoma medication. Our study is a long-term, case–control analysis of how systemic antihypertensive (anti-HTN) medications influence the change in IOP after initiating prostaglandin (PG) drop therapy.Materials and methods: A retrospective chart review of 3,781 patients was performed on patients with a diagnosis of glaucoma suspect that progressed to primary open-angle glaucoma (POAG) by ICD-9 codes over a 10-year period. Inclusion criteria consisted of the following: 1) progression from preglaucoma to glaucoma diagnosis in a time span of ≥6 months; 2) two visual fields recorded between these dates; 3) initial average IOP of both eyes of ≥21 mmHg; and 4) initiation of topical PG therapy alone. IOP (in mmHg) was measured at initiation of PG drops and at next visit.Results: One hundred eleven patients were qualified for analysis. Patients not on anti-HTN agents had an average IOP decrease of 6.38±0.56 mmHg. Comparatively, patients on anti-HTN agents had an average IOP decrease of 6.66±0.48 mmHg (P=0.61). In addition, there was no statistical difference between IOP decrease between patients on single vs multiple systemic anti-HTN agents (P=0.85). There were eight nonresponders to PGs on no anti-HTN medications and 12 nonresponders on anti-HTN medication (P=0.55).Conclusion: Systemic anti-HTN medication use did not significantly impact IOP reduction after topical PG initiation for POAG. Additionally, nonresponse to PG therapy was not correlated to systemic anti-HTN use. Keywords: glaucoma, topical prostaglandins, IOP, systemic antihypertensives, ocular hypertension, prostaglandin eye drops |
format |
article |
author |
Siddiqui M Iltis J Yanev P Sladic J Huynh C Nolan D Singer M |
author_facet |
Siddiqui M Iltis J Yanev P Sladic J Huynh C Nolan D Singer M |
author_sort |
Siddiqui M |
title |
Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma |
title_short |
Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma |
title_full |
Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma |
title_fullStr |
Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma |
title_full_unstemmed |
Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma |
title_sort |
effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma |
publisher |
Dove Medical Press |
publishDate |
2019 |
url |
https://doaj.org/article/fd1be763babf43ad9c80030ff97ac9a4 |
work_keys_str_mv |
AT siddiquim effectofsystemicantihypertensivesonchangeinintraocularpressureafterinitiatingtopicalprostaglandinsforprimaryopenangleglaucoma AT iltisj effectofsystemicantihypertensivesonchangeinintraocularpressureafterinitiatingtopicalprostaglandinsforprimaryopenangleglaucoma AT yanevp effectofsystemicantihypertensivesonchangeinintraocularpressureafterinitiatingtopicalprostaglandinsforprimaryopenangleglaucoma AT sladicj effectofsystemicantihypertensivesonchangeinintraocularpressureafterinitiatingtopicalprostaglandinsforprimaryopenangleglaucoma AT huynhc effectofsystemicantihypertensivesonchangeinintraocularpressureafterinitiatingtopicalprostaglandinsforprimaryopenangleglaucoma AT noland effectofsystemicantihypertensivesonchangeinintraocularpressureafterinitiatingtopicalprostaglandinsforprimaryopenangleglaucoma AT singerm effectofsystemicantihypertensivesonchangeinintraocularpressureafterinitiatingtopicalprostaglandinsforprimaryopenangleglaucoma |
_version_ |
1718400629749055488 |